You searched for viral vector - Page 36 of 53

News and Trends 14 Jun 2017

French Hepatitis Cure is on Track with Positive Phase I Results

…and is able to interfere with HBV replication by impacting the transcriptional activity of cccDNA, which serves as a template for all viral RNAs. In addition, FXR agonists have recently…

June 14, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 8 Jul 2020

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

…being investigated, such as the antiviral favipiravir, which is currently in clinical trials, and the antiparasitic drug ivermectin, which has shown early promise in preclinical studies. Remdesivir is one of…

July 8, 2020 - 3 minutesmins - By Victor Kotsev

In Depth 30 Apr 2025

The future of NSCLC treatment: what’s in store for the therapeutic space?

…antiviral given in combination with CAN-2409 – into a toxic substance that kills cancer cells. Given together, the drugs boost a T cell-mediated response against tumors. In a phase 2a…

April 30, 2025 - 12 minutesmins - By Roohi Mariam Peter

Interview 1 Feb 2021

Democratized DNA Synthesis: A Game-Changer Against Covid-19

…particularly those that detect viral genetic material via a technique called PCR. With widespread testing, it’s possible to isolate infected people and slow the spread of the virus. “All PCR…

February 1, 2021 - 6 minutesmins - By Jonathan Smith

News and Trends 7 Sep 2022

TikoMed drug inhibits infection of human cells by dengue, zika and yellow fever viruses

…serotypes of dengue virus (DENV1-4), two strains of zika virus (African and Asian) and yellow fever virus (vaccine strain YF17D) assessed by immunofluorescence of viral particles. In the study, ILB…

September 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 22 Aug 2019

Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III

…virus with an injectable regimen containing two drugs administered every two months,” stated Kimberly Smith, Head of Research & Development at ViiV Healthcare. The treatment consists of two antiviral drugs…

August 22, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 16 Feb 2022

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

…and botulism. Ossianix has also shown that its antibodies could be effective against Covid-19 infections. ReViral Founded: 2011 ReViral develops antiviral therapies focusing on the respiratory syncytial virus (RSV), which…

February 16, 2022 - 6 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 28 Mar 2024

Are these T cell receptor (TCR) therapy companies on your radar?

…IMC-F106C in combination with the latter’s immune checkpoint inhibitor, nivolumab, in first-line advanced cutaneous melanoma. Lion TCR With operations in Singapore and China, Lion TCR aims to tackle viral infections…

March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 9 Jan 2023

ErVaccine raises €4.5M to start therapeutic cancer vaccine trial

…of the human genome consists of sequences of retroviral origin, namely HERVs. HERVs are remnants of ancient retroviral infections that affected the germ line of primates and their ancestors over…

January 9, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 Feb 2023

Immuno Cure starts HIV drug trial

…Life-long antiretroviral treatment (ART) neither cures HIV/AIDS nor fully restores immune function, so Immuno Cure says it is critical to discover an effective immunotherapy of potentiating host immunity to achieve…

February 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 8 May 2018

Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

TC Biopharm has partnered with Scotia Biologics to produce tumor-specific antibodies for a new generation of safer CAR-T therapies against multiple types of tumors as well as viral infections such…

May 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Feb 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

…which express viral RNA biomarkers distinct from human cellular RNA. By targeting these specific viral RNA sequences, Akribion Therapeutics’ G-dase E technology aims to selectively deplete cancerous cells while sparing…

February 4, 2025 - 6 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

French Hepatitis Cure is on Track with Positive Phase I Results

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

The future of NSCLC treatment: what’s in store for the therapeutic space?

Democratized DNA Synthesis: A Game-Changer Against Covid-19

TikoMed drug inhibits infection of human cells by dengue, zika and yellow fever viruses

Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

Are these T cell receptor (TCR) therapy companies on your radar?

ErVaccine raises €4.5M to start therapeutic cancer vaccine trial

Immuno Cure starts HIV drug trial

Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!